Global antifungal agents market was valued US$ 12.8 Bn in 2019 and is expected to reach US$ 17.6 Bn by 2026, at a CAGR of 4.06 % during a forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The antifungal agents are fungistatic in nature and are used to prevent and treat fungal infections such as candidiasis, ringworm, etc. Antifungal is basically the drugs which help in detecting and eliminating fungal pathogens from the foreign body with less toxic side effects to the body.
The significant driver increasing growth in the global antifungal agents market is the progress of drug resistance. The rising concern amongst the population regarding health issue has positively influenced the growth in the medical sector. The infections like yeasts and pathogenic fungi can occupy and overtake the human body. Therefore, there is an increasing demand for antifungal drugs in the market. Alternate treatment options and regulatory atmosphere are the major factors obstructing the growth of the antifungal agents market.
Tropical drugs are the emerging application, which is directly applied to the skin or the affected portion of the body. Tropical drugs come in wide forms like pastes, ointments, powder, and others. Oral antifungal agents include fluconazole, terbinafine, itraconazole, and ketoconazole. Oral antifungal agents are kept for serious infection for which topical antifungal agents are ineffective or inappropriate. Oral antifungal agents are medicines, which are available only through prescription and dosage forms like capsules, suspensions, and tablets.
Aspergillosis therapeutic indication is leading the market. Aspergillosis contains allergic reactions, lung infections, and infections in other organs. The common of cases occur in people with underlying illnesses such as tuberculosis or chronic obstructive pulmonary disease, but with otherwise healthy immune systems.
North America is expected to hold the largest share during the forecast period owing to the huge investments made in drug productions along with government initiatives related to fungal infections and their treatment. Asia-Pacific is projected to be the fastest-growing region for the antifungal agents market owing to the growing healthcare industry is boosting the antifungal agents market. China is expected to register major market growth in antifungal drugs owing to the rising access of public with healthcare professional and growing economy.
The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
For More Information Visit :https://www.maximizemarketresearch.com/market-report/global-antifungal-agents-market/23804/
The Scope of Global Antifungal Agents Market:
Global Antifungal Agents Market, by Drug Types:
• Systemic Azoles & Polyenes
• Topical Azoles & Polyenes
• Systemic Echinocandins & Antimetabolics
• Other Drugs Types
Global Antifungal Agents Market, by Therapeutic Indications:
• Aspergillosis Therapeutic Indications
• Dermatophytosis Therapeutic Indications
• Candidiasis Therapeutic Indications
• Others Therapeutic Indications
Global Antifungal Agents Market, by Types:
• Prescription
• Over the counter (OTC)
Global Antifungal Agents Market, by Applications:
• Topical Antifungal Agents Applications
• Oral Drugs Applications
Global Antifungal Agents Market, by Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
Key Player Operating In the Global Antifungal Agents Market:
• Abbott Laboratories, Inc.
• Amplyx Pharmaceuticals, Inc.
• Astellas Pharma, Inc.
• Basilea Pharmaceutica AG
• Bayer Healthcare LLC
• Bristol-Myers Squibb Pharmaceuticals, Ltd.
• Cosmo Pharmaceuticals NV
• Gilead Sciences, Inc.
• Janssen Pharmaceutica NV
• Mayne Pharma, Inc.
• Merck & Co., Inc.
• Mylan Pharmaceuticals, Inc.
• Nouvasant Pharmhealth Ltd.
• Pfizer, Inc.
• Sanofi-Aventis U.S. LLC
• Scynexis, Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Sun Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industries, Ltd.
• Zydus Cadila Healthcare Ltd.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Address : Pune, Maharashtra 411051, India.
Contact: +919607195908
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The antifungal agents are fungistatic in nature and are used to prevent and treat fungal infections such as candidiasis, ringworm, etc. Antifungal is basically the drugs which help in detecting and eliminating fungal pathogens from the foreign body with less toxic side effects to the body.
The significant driver increasing growth in the global antifungal agents market is the progress of drug resistance. The rising concern amongst the population regarding health issue has positively influenced the growth in the medical sector. The infections like yeasts and pathogenic fungi can occupy and overtake the human body. Therefore, there is an increasing demand for antifungal drugs in the market. Alternate treatment options and regulatory atmosphere are the major factors obstructing the growth of the antifungal agents market.
Tropical drugs are the emerging application, which is directly applied to the skin or the affected portion of the body. Tropical drugs come in wide forms like pastes, ointments, powder, and others. Oral antifungal agents include fluconazole, terbinafine, itraconazole, and ketoconazole. Oral antifungal agents are kept for serious infection for which topical antifungal agents are ineffective or inappropriate. Oral antifungal agents are medicines, which are available only through prescription and dosage forms like capsules, suspensions, and tablets.
Aspergillosis therapeutic indication is leading the market. Aspergillosis contains allergic reactions, lung infections, and infections in other organs. The common of cases occur in people with underlying illnesses such as tuberculosis or chronic obstructive pulmonary disease, but with otherwise healthy immune systems.
North America is expected to hold the largest share during the forecast period owing to the huge investments made in drug productions along with government initiatives related to fungal infections and their treatment. Asia-Pacific is projected to be the fastest-growing region for the antifungal agents market owing to the growing healthcare industry is boosting the antifungal agents market. China is expected to register major market growth in antifungal drugs owing to the rising access of public with healthcare professional and growing economy.
The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
For More Information Visit :https://www.maximizemarketresearch.com/market-report/global-antifungal-agents-market/23804/
The Scope of Global Antifungal Agents Market:
Global Antifungal Agents Market, by Drug Types:
• Systemic Azoles & Polyenes
• Topical Azoles & Polyenes
• Systemic Echinocandins & Antimetabolics
• Other Drugs Types
Global Antifungal Agents Market, by Therapeutic Indications:
• Aspergillosis Therapeutic Indications
• Dermatophytosis Therapeutic Indications
• Candidiasis Therapeutic Indications
• Others Therapeutic Indications
Global Antifungal Agents Market, by Types:
• Prescription
• Over the counter (OTC)
Global Antifungal Agents Market, by Applications:
• Topical Antifungal Agents Applications
• Oral Drugs Applications
Global Antifungal Agents Market, by Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
Key Player Operating In the Global Antifungal Agents Market:
• Abbott Laboratories, Inc.
• Amplyx Pharmaceuticals, Inc.
• Astellas Pharma, Inc.
• Basilea Pharmaceutica AG
• Bayer Healthcare LLC
• Bristol-Myers Squibb Pharmaceuticals, Ltd.
• Cosmo Pharmaceuticals NV
• Gilead Sciences, Inc.
• Janssen Pharmaceutica NV
• Mayne Pharma, Inc.
• Merck & Co., Inc.
• Mylan Pharmaceuticals, Inc.
• Nouvasant Pharmhealth Ltd.
• Pfizer, Inc.
• Sanofi-Aventis U.S. LLC
• Scynexis, Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Sun Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industries, Ltd.
• Zydus Cadila Healthcare Ltd.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Address : Pune, Maharashtra 411051, India.
Contact: +919607195908
Comments
Post a Comment